about
Nanotoxicology - a pathologist's perspectiveToxicology of nanomaterials used in nanomedicineToxicological Considerations, Toxicity Assessment, and Risk Management of Inhaled NanoparticlesDevelopment of Taiwan's strategies for regulating nanotechnology-based pharmaceuticals harmonized with international considerationsQSAR modeling: where have you been? Where are you going to?Toxicity of engineered nanomaterials: a physicochemical perspectiveEmerging methods and tools for environmental risk assessment, decision-making, and policy for nanomaterials: summary of NATO Advanced Research WorkshopHigh dispersity of carbon nanotubes diminishes immunotoxicity in spleenNanoparticles and neurotoxicityNano delivers big: designing molecular missiles for cancer therapeutics.Gold nanoclusters as novel optical probes for in vitro and in vivo fluorescence imagingCurrent approaches of the management of mercury poisoning: need of the hour.The changes of T lymphocytes and cytokines in ICR mice fed with Fe3O4 magnetic nanoparticles.TiO2 micro-nano-hybrid surface to alleviate biological aging of UV-photofunctionalized titaniumDetermination of the surface density of polyethylene glycol on gold nanoparticles by use of microscale thermogravimetric analysis.Multi-walled carbon nanotubes inhibit regenerative axon growth of dorsal root ganglia neurons of mice.Toxicity evaluation of biodegradable chitosan nanoparticles using a zebrafish embryo model.Brain Localization and Neurotoxicity Evaluation of Polysorbate 80-Modified Chitosan Nanoparticles in Rats.Nanoparticulated docetaxel exerts enhanced anticancer efficacy and overcomes existing limitations of traditional drugsThe comparative immunotoxicity of mesoporous silica nanoparticles and colloidal silica nanoparticles in miceTitanium dioxide nanoparticles increase inflammatory responses in vascular endothelial cells.Multifunctional to multistage delivery systems: The evolution of nanoparticles for biomedical applicationsNanotechnology in joint replacement.Rapamycin ameliorates chitosan nanoparticle-induced developmental defects of preimplantation embryos in mice.Nanosilver and global public health: international regulatory issues.Bionanoelectronics.Synthesis and bio-functionalization of magnetic nanoparticles for medical diagnosis and treatment.Nanotoxicology and nanoparticle safety in biomedical designsAdvances in pulmonary delivery of nanoparticles.Next-generation nanomedicines and nanosimilars: EU regulators' initiatives relating to the development and evaluation of nanomedicines.Graphene nanomaterials as biocompatible and conductive scaffolds for stem cells: impact for tissue engineering and regenerative medicine.Ceramic nanoparticles: Recompense, cellular uptake and toxicity concerns.Biocompatibility and nanostructured materials: applications in nanomedicine.Bio-effect of nanoparticles in the cardiovascular system.Rethinking risk assessment for emerging technology first-in-human trials.Gd(3+)-DTPA-DG: novel nanosized dual anticancer and molecular imaging agent.In vitro cytotoxicity screening of water-dispersible metal oxide nanoparticles in human cell lines.Evaluation of the genotoxicity of chitosan nanoparticles for use in food packaging films.Tiopronin monolayer-protected silver nanoparticles modulate IL-6 secretion mediated by Toll-like receptor ligands.Bismuth oxide aqueous colloidal nanoparticles inhibit Candida albicans growth and biofilm formation.
P2860
Q23909944-AAFF8D54-C7E5-4A04-82BD-4ED88C946D7FQ23914977-5F0A38D4-F8F5-4847-8C72-6501D69EA402Q26744511-CF95BEA0-F868-47AD-8BF9-AB4E01DE3B57Q27687656-6F13D21A-A0CB-4FA6-9CB7-6BEB0F79886FQ28222668-A766776B-CC94-4C89-9C32-1BAE77D32958Q28388891-199ABC71-E989-40C5-BDB0-BFABF0BB60D6Q28390053-85789353-857C-4C85-ACAA-23F14F0F7551Q28391372-68052A71-CCF6-487F-8E7E-22D5B27C8817Q28392496-8178D15A-CCAA-4EFD-BBC1-EE69C8AA025AQ30470080-5A7720C4-52D5-40A6-90D8-A35BFA31EF06Q33659281-3819F525-13D3-428F-A99C-336187CB5C41Q33749569-FC9DEDB6-4B0F-4880-93B7-F81C7D4EA83FQ35023306-0D0FB506-702A-495E-8629-A5B79C7E5216Q35097023-604F1601-860F-4CED-B7C2-0EB7F8E39948Q35564828-1418D3E5-3FA0-44F7-B496-33D419B9F67DQ35658594-2586B78A-3927-4A61-BB93-F51FD436C00BQ35677162-802E8085-96AD-463E-92BE-4AC1ED92FFF6Q35739007-DAD46D3C-1AFC-4EF5-B246-BEAF26398FBEQ36137260-13E0FC95-530D-4392-9767-DB1EBD05CAB8Q36530323-D27D1293-9093-42D3-877A-E05A5E4B48E2Q36781382-C88E18DF-FB6A-4EE2-A899-FB38F3539E57Q37609544-53BA4ADF-3D7A-4F8E-BE12-756819D5708FQ37668377-2784378F-1196-4703-8830-A38020DE2E9FQ37688830-3B2D85D9-B2AE-4001-A748-DFBFF9B2DE81Q37763154-F4A00B7D-4E88-448C-A72E-C687E32152E5Q37843981-A4183574-2C89-4712-87C9-1AC51229EC44Q37848104-7FB91EE4-3BBC-47FC-B00B-85B3AA229564Q37893481-438ED17A-800E-412F-8B38-D73AE08D4D40Q37909465-81ABF5DB-7799-4A60-8415-0E1168DAC5FEQ38105142-8823E0E7-6354-4145-9F97-65AD69D04214Q38219380-328C4002-314C-4C69-B867-F4D0E70CE6B1Q38250374-33E9A25D-6928-4DA5-B5B6-4A71C787C2AFQ38849743-FDC8DC2E-C427-4268-B4E3-9E55E5A682CBQ38865230-06A361BA-1592-4FE9-95AA-CDD85A582757Q38974025-EDFD5D72-E571-4FBA-94E0-C8600095E38AQ39540783-01E28F06-327B-4249-8EBA-C512312F6468Q39820009-1A47D594-86D5-4780-8E44-832C2392FEB4Q39845968-AD138057-BE67-404C-A256-2BD71DB18E75Q39932833-AC86CE6A-0620-40D7-9172-EC280139B65DQ40210339-E115B1F3-AFA9-42BD-9DBB-B3CD89775B5D
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 10 March 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Nanotoxicology and nanomedicine: making hard decisions.
@en
Nanotoxicology and nanomedicine: making hard decisions.
@nl
type
label
Nanotoxicology and nanomedicine: making hard decisions.
@en
Nanotoxicology and nanomedicine: making hard decisions.
@nl
prefLabel
Nanotoxicology and nanomedicine: making hard decisions.
@en
Nanotoxicology and nanomedicine: making hard decisions.
@nl
P1476
Nanotoxicology and nanomedicine: making hard decisions
@en
P2093
Igor Linkov
Lisa M Corey
P304
P356
10.1016/J.NANO.2008.01.001
P577
2008-03-10T00:00:00Z